Eli Lilly loses Alimta drug patent case in Germany to Actavis

(Reuters) - Eli Lilly has lost a patent case in Germany over its blockbuster Alimta lung cancer drug to generic producer Actavis, hitting the U.S. drugmaker's future sales hopes for the medicine.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news